Amarin Corp Plc (AMRN)

[dogn]

https://www.springermedizin.de/hypercholesterinaemie/praevention-und-rehabilitation-in-der-kardiologie/triglyzeridsenker-schuetzt-nicht-nur-hochrisikopatienten/27045912

Icosapent Ethyl for cardiovascular risk reduction (apparently featuring recent ACC24 data) published in yesterday’s news section of German SpringerMedizin.de - My expertise

Better informed doctors make better decisions.

The bundled expertise from all specialties supports you in keeping an eye on medical progress and being able to offer the best possible treatment.

https://www.springermedizin.de/

10.05.2024 | Hypercholesterolemia | News

Cardiovascular prevention
Triglyceride reducer not only protects high-risk patients
written by: Dr. Dagmar Kraus

Log in to get access
The triglyceride-lowering omega-3 fatty acid derivative Icosapent-Ethyl is used for cardiovascular prevention in high-risk patients. Whether the intake is worthwhile for all patients with atherosclerosis-related cardiovascular diseases and elevated triglyceride levels was the subject of a recent analysis.

Progress towards German resubmission

Dogn